A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium

NCT00949455 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: lapatinib ditosylate
OTHER: Placebo

Sponsor

Queen Mary University of London

Collaborators

[object Object]